Ives Jeffrey L. 4
4 · Acumen Pharmaceuticals, Inc. · Filed Jun 5, 2025
Insider Transaction Report
Form 4
Ives Jeffrey L.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-04+19,500→ 19,500 totalExercise: $1.07Exp: 2035-06-04→ Common Stock (19,500 underlying) - Award
Common Stock
2025-06-04+12,800→ 12,800 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.
- [F2]The shares subject to the option will vest in full on the earlier of the first anniversary of the date of grant or the 2026 annual stockholder meeting, subject to the Reporting Person's continuous service through such vesting date.